Martin A Mattingly's Net Worth

$13.4 Thousand

Estimate Recalculated Apr 23, 2024 03:41PM EST

Who is Martin A Mattingly?

Martin A Mattingly does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Tracon Pharmaceuticals, Inc., ACHIEVE LIFE SCIENCES, INC., TRIMERIS INC, and CANCERVAX CORP.

SEC CIK

Martin A Mattingly's CIK is 0001265782

Past Insider Trading and Trends

2015 was Martin A Mattingly's most active year for acquiring shares with 6 total transactions. Martin A Mattingly's most active month to acquire stocks was the month of April. 2009 was Martin A Mattingly's most active year for disposing of shares, totalling 3 transactions. Martin A Mattingly's most active month to dispose stocks was the month of April. 2013 saw Martin A Mattingly paying a total of $21,280.00 for 9,500 shares, this is the most they've acquired in one year. In 2009 Martin A Mattingly cashed out on 528,176 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.1929

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 19
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 15
Form 4
∞
7.5K
—
—
7.5K
Jun 1
Form 4
—
0
—
—
0
Jul 23
Form 4
—
0
—
—
0
Mar 4
Form 3
—
0
—
—
0
No matching records found

ACHIEVE LIFE SCIENCES, INC. (ACHV) Snapshot price: $4.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Sep 20
Form 4/A
—
0
—
—
0
Aug 1
Form 4
—
0
—
—
0
Aug 1
Form 4
—
0
—
—
0
May 26
Form 4
+31.25%
2.5K
—
—
10.5K
May 20
Form 4
+45.45%
2.5K
—
—
8K
May 20 - May 21
Form 4
+83.33%
2.5K
—
—
5.5K
Jun 5
Form 4
+200.00%
2K
$10.64
$21,280.00
3K
May 23 - May 24
Form 4
∞
1K
$12.46
$12,460.00
1K
May 31 - Jun 1
Form 4
—
0
—
—
0
Jun 8
Form 3
—
0
—
—
0
No matching records found

TRIMERIS INC No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 22
Form 4
—
0
—
—
0
Jul 21
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Aug 6
Form 4
—
0
—
—
0
Jun 26
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Nov 14
No matching records found

CANCERVAX CORP No price found

Exec. VP, Marketing & Bus. Dev

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 14
Form 4
∞
11.25K
—
—
11.25K
Feb 9
Form 4
—
0
—
—
0
Feb 27
Form 3
—
0
—
—
0
No matching records found